Management of the Donor and Recipient: Surgical Management

  • Andrea Mariscal
  • Shaf KeshavjeeEmail author


The world’s first successful lung transplant was performed more than 30 years ago; since then there have been significant advancements not only in the donor management and the preservation technique but also related to the surgical procedure itself. The operative mortality and early and late outcomes continue to improve. The objective of this chapter is to describe the donor management, the surgical techniques of bilateral lung transplantation as performed in the Toronto Lung Transplant Program, as well as the most important complications during the donor surgery, recipient surgery, and after the transplant.


Donor lung retrieval and preservation Perioperative management of the lung allograft Perioperative management of the lung transplant recipient Surgical and other perioperative complications 


  1. 1.
    Orens JB, Boehler A, de Perrot M, Estenne M, Glanville AR, Keshavjee S, et al. A review of lung transplant donor acceptability criteria. J Heart Lung Transplant. 2003;22(11):1183–200.PubMedCrossRefGoogle Scholar
  2. 2.
    Pierre AF, Keshavjee S. Lung transplantation: donor and recipient critical care aspects. Curr Opin Crit Care. 2005;11(4):339–44.PubMedCrossRefGoogle Scholar
  3. 3.
    Botha P. Extended donor criteria in lung transplantation. Curr Opin Organ Transplant. 2009;14(2):206–10.PubMedCrossRefGoogle Scholar
  4. 4.
    Cypel M, Keshavjee S. Strategies for safe donor expansion: donor management, donations after cardiac death, ex-vivo lung perfusion. Curr Opin Organ Transplant. 2013;18(5):513–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Daemen JW, Kootstra G, Wijnen RM, Yin M, Heineman E. Nonheart-beating donors: the Maastricht experience. Clin Transpl. 1994:303–16.Google Scholar
  6. 6.
    Levvey BJ, Harkess M, Hopkins P, Chambers D, Merry C, Glanville AR, et al. Excellent clinical outcomes from a national donation-after-determination-of-cardiac-death lung transplant collaborative. Am J Transplant. 2012;12(9):2406–13.PubMedCrossRefGoogle Scholar
  7. 7.
    Cypel M, Sato M, Yildirim E, Karolak W, Chen F, Yeung J, et al. Initial experience with lung donation after cardiocirculatory death in Canada. J Heart Lung Transplant. 2009;28(8):753–8.PubMedCrossRefGoogle Scholar
  8. 8.
    De Oliveira NC, Osaki S, Maloney JD, Meyer KC, Kohmoto T, D’Alessandro AM, et al. Lung transplantation with donation after cardiac death donors: long-term follow-up in a single center. J Thorac Cardiovasc Surg. 2010;139(5):1306–15.PubMedCrossRefGoogle Scholar
  9. 9.
    Love RB. Perspectives on lung transplantation and donation-after-determination-of-cardiac-death donors. Am J Transplant. 2012;12(9):2271–2.PubMedCrossRefGoogle Scholar
  10. 10.
    Munshi L, Keshavjee S, Cypel M. Donor management and lung preservation for lung transplantation. Lancet Respir Med. 2013;1(4):318–28.PubMedCrossRefGoogle Scholar
  11. 11.
    Franklin GA, Santos AP, Smith JW, Galbraith S, Harbrecht BG, Garrison RN. Optimization of donor management goals yields increased organ use. Am Surg. 2010;76(6):587–94.PubMedGoogle Scholar
  12. 12.
    Toyoda Y, McCurry KR. Prior cardiac surgery is not a contraindication for lung donor. Ann Thorac Surg. 2007;84(1):314–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Das De S, Nenekidis I, Itrakjy A, Mascaro J. Bilateral lung transplantation from a donor with previous aortic valve surgery. Asian Cardiovasc Thorac Ann. 2016;24(4):375–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Schmidt F, McGiffin DC, Zorn G, Young KR, Weill D, Kirklin JK. Management of congenital abnormalities of the donor lung. Ann Thorac Surg. 2001;72(3):935–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Sekine Y, Fischer S, de Perrot M, Pierre AF, Keshavjee S. Bilateral lung transplantation using a donor with a tracheal right upper lobe bronchus. Ann Thorac Surg. 2002;73(1):308–10.PubMedCrossRefGoogle Scholar
  16. 16.
    Brichon PY, Blin D, Perez I, Pison C, Blanc-Jouvan F, Pin I, et al. Double-lung transplantation using donor lungs with a right tracheal bronchus. Ann Thorac Surg. 1992;54(4):777–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Olland A, Reeb J, Falcoz PE, Garnon J, Germain P, Santelmo N, et al. Anomalous pulmonary venous return of the left upper lobe in a donor lung. Ann Thorac Surg. 2015;99(6):2199–202.PubMedCrossRefGoogle Scholar
  18. 18.
    Khasati NH, MacHaal A, Thekkudan J, Kumar S, Yonan N. An aberrant donor pulmonary vein during lung transplant: a surgical challenge. Ann Thorac Surg. 2005;79(1):330–1.PubMedCrossRefGoogle Scholar
  19. 19.
    Melvan JN, Force SD, Sancheti MS. Anatomic resection to manage donor partial anomalous pulmonary venous return during lung transplantation: a case report and review. Transplant Proc. 2015;47(3):846–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Machuca TN, Cypel M, Keshavjee S. Advances in lung preservation. Surg Clin North Am. 2013;93(6):1373–94.PubMedCrossRefGoogle Scholar
  21. 21.
    Hall SM, Komai H, Reader J, Haworth SG. Donor lung preservation: effect of cold preservation fluids on cultured pulmonary endothelial cells. Am J Physiol. 1994;267(5 Pt 1):L508–17.PubMedGoogle Scholar
  22. 22.
    de Perrot M, Keshavjee S. Lung preservation. Semin Thorac Cardiovasc Surg. 2004;16(4):300–8.PubMedCrossRefGoogle Scholar
  23. 23.
    Fujimura S, Handa M, Kondo T, Ichinose T, Shiraishi Y, Nakada T. Successful 48-hour simple hypothermic preservation of canine lung transplants. Transplant Proc. 1987;19(1 Pt 2):1334–6.PubMedGoogle Scholar
  24. 24.
    Keshavjee SH, Yamazaki F, Cardoso PF, McRitchie DI, Patterson GA, Cooper JD. A method for safe twelve-hour pulmonary preservation. J Thorac Cardiovasc Surg. 1989;98(4):529–34.PubMedGoogle Scholar
  25. 25.
    Date H, Matsumura A, Manchester JK, Obo H, Lima O, Cooper JM, et al. Evaluation of lung metabolism during successful twenty-four-hour canine lung preservation. J Thorac Cardiovasc Surg. 1993;105(3):480–91.PubMedGoogle Scholar
  26. 26.
    Thabut G, Vinatier I, Brugiere O, Leseche G, Loirat P, Bisson A, et al. Influence of preservation solution on early graft failure in clinical lung transplantation. Am J Respir Crit Care Med. 2001;164(7):1204–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Fischer S, Matte-Martyn A, De Perrot M, Waddell TK, Sekine Y, Hutcheon M, et al. Low-potassium dextran preservation solution improves lung function after human lung transplantation. J Thorac Cardiovasc Surg. 2001;121(3):594–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Arnaoutakis GJ, Allen JG, Merlo CA, Baumgartner WA, Conte JV, Shah AS. Low potassium dextran is superior to University of Wisconsin solution in high-risk lung transplant recipients. J Heart Lung Transplant. 2010;29(12):1380–7.PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Wang LS, Nakamoto K, Hsieh CM, Miyoshi S, Cooper JD. Influence of temperature of flushing solution on lung preservation. Ann Thorac Surg. 1993;55(3):711–5.PubMedCrossRefGoogle Scholar
  30. 30.
    Date H, Lima O, Matsumura A, Tsuji H, d’Avignon DA, Cooper JD. In a canine model, lung preservation at 10 degrees C is superior to that at 4 degrees C. A comparison of two preservation temperatures on lung function and on adenosine triphosphate level measured by phosphorus 31-nuclear magnetic resonance. J Thorac Cardiovasc Surg. 1992;103(4):773–80.PubMedGoogle Scholar
  31. 31.
    Albes JM, Fischer F, Bando T, Heinemann MK, Scheule A, Wahlers T. Influence of the perfusate temperature on lung preservation: is there an optimum? Eur Surg Res. 1997;29(1):5–11.PubMedCrossRefGoogle Scholar
  32. 32.
    Struber M, Hohlfeld JM, Kofidis T, Warnecke G, Niedermeyer J, Sommer SP, et al. Surfactant function in lung transplantation after 24 hours of ischemia: advantage of retrograde flush perfusion for preservation. J Thorac Cardiovasc Surg. 2002;123(1):98–103.PubMedCrossRefGoogle Scholar
  33. 33.
    Baretti R, Bitu-Moreno J, Beyersdorf F, Matheis G, Francischetti I, Kreitmayr B. Distribution of lung preservation solutions in parenchyma and airways: influence of atelectasis and route of delivery. J Heart Lung Transplant. 1995;14(1 Pt 1):80–91.PubMedGoogle Scholar
  34. 34.
    Sakuma T, Tsukano C, Ishigaki M, Nambu Y, Osanai K, Toga H, et al. Lung deflation impairs alveolar epithelial fluid transport in ischemic rabbit and rat lungs. Transplantation. 2000;69(9):1785–93.PubMedCrossRefGoogle Scholar
  35. 35.
    Haniuda M, Hasegawa S, Shiraishi T, Dresler CM, Cooper JD, Patterson GA. Effects of inflation volume during lung preservation on pulmonary capillary permeability. J Thorac Cardiovasc Surg. 1996;112(1):85–93.PubMedCrossRefGoogle Scholar
  36. 36.
    Kirk AJ, Colquhoun IW, Dark JH. Lung preservation: a review of current practice and future directions. Ann Thorac Surg. 1993;56(4):990–100.PubMedCrossRefGoogle Scholar
  37. 37.
    Kayano K, Toda K, Naka Y, Pinsky DJ. Identification of optimal conditions for lung graft storage with Euro-Collins solution by use of a rat orthotopic lung transplant model. Circulation. 1999;100(19 Suppl):II257–61.PubMedGoogle Scholar
  38. 38.
    de Perrot M, Fischer S, Liu M, Jin R, Bai XH, Waddell TK, et al. Prostaglandin E1 protects lung transplants from ischemia-reperfusion injury: a shift from pro- to anti-inflammatory cytokines. Transplantation. 2001;72(9):1505–12.PubMedCrossRefGoogle Scholar
  39. 39.
    Chen CZ, Gallagher RC, Ardery P, Dyckman W, Donabue S, Low HB. Retrograde flush and cold storage for twenty-two to twenty-five hours lung preservation with and without prostaglandin E1. J Heart Lung Transplant. 1997;16(6):658–66.PubMedGoogle Scholar
  40. 40.
    de Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med. 2003;167(4):490–511.PubMedCrossRefGoogle Scholar
  41. 41.
    Steen S, Liao Q, Wierup PN, Bolys R, Pierre L, Sjoberg T. Transplantation of lungs from non-heart-beating donors after functional assessment ex vivo. Ann Thorac Surg. 2003;76(1):244–52, discussion 252PubMedCrossRefGoogle Scholar
  42. 42.
    Steen S, Ingemansson R, Eriksson L, Pierre L, Algotsson L, Wierup P, et al. First human transplantation of a nonacceptable donor lung after reconditioning ex vivo. Ann Thorac Surg. 2007;83(6):2191–4.PubMedCrossRefGoogle Scholar
  43. 43.
    Erasmus ME, Fernhout MH, Elstrodt JM, Rakhorst G. Normothermic ex vivo lung perfusion of non-heart-beating donor lungs in pigs: from pretransplant function analysis towards a 6-h machine preservation. Transpl Int. 2006;19(7):589–93.PubMedCrossRefGoogle Scholar
  44. 44.
    Cypel M, Yeung JC, Hirayama S, Rubacha M, Fischer S, Anraku M, et al. Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant. 2008;27(12):1319–25.PubMedCrossRefGoogle Scholar
  45. 45.
    Cypel M, Yeung JC, Machuca T, Chen M, Singer LG, Yasufuku K, et al. Experience with the first 50 ex vivo lung perfusions in clinical transplantation. J Thorac Cardiovasc Surg. 2012;144(5):1200–6.PubMedPubMedCentralCrossRefGoogle Scholar
  46. 46.
    Cypel M, Liu M, Rubacha M, Yeung JC, Hirayama S, Anraku M, et al. Functional repair of human donor lungs by IL-10 gene therapy. Sci Transl Med. 2009;1(4):4ra9.PubMedCrossRefGoogle Scholar
  47. 47.
    Andreasson AS, Dark JH, Fisher AJ. Ex vivo lung perfusion in clinical lung transplantation–state of the art. Eur J Cardiothorac Surg. 2014;46(5):779–88.PubMedCrossRefGoogle Scholar
  48. 48.
    Warnecke G, Moradiellos J, Tudorache I, Kuhn C, Avsar M, Wiegmann B, et al. Normothermic perfusion of donor lungs for preservation and assessment with the Organ Care System Lung before bilateral transplantation: a pilot study of 12 patients. Lancet. 2012;380(9856):1851–8.PubMedCrossRefGoogle Scholar
  49. 49.
    de Perrot M, Keshavjee S. Everting mattress running suture: an improved technique of atrial anastomosis in human lung transplantation. Ann Thorac Surg. 2002;73(5):1663–4.PubMedCrossRefGoogle Scholar
  50. 50.
    Pierre AF, DeCampos KN, Liu M, Edwards V, Cutz E, Slutsky AS, et al. Rapid reperfusion causes stress failure in ischemic rat lungs. J Thorac Cardiovasc Surg. 1998;116(6):932–42.PubMedCrossRefGoogle Scholar
  51. 51.
    Marczin N, Royston D, Yacoub M. Pro: lung transplantation should be routinely performed with cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2000;14(6):739–45.PubMedCrossRefGoogle Scholar
  52. 52.
    McRae K. Con: lung transplantation should not be routinely performed with cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2000;14(6):746–50.PubMedCrossRefGoogle Scholar
  53. 53.
    Zangrillo A, Garozzo FA, Biondi-Zoccai G, Pappalardo F, Monaco F, Crivellari M, et al. Miniaturized cardiopulmonary bypass improves short-term outcome in cardiac surgery: a meta-analysis of randomized controlled studies. J Thorac Cardiovasc Surg. 2010;139(5):1162–9.PubMedCrossRefGoogle Scholar
  54. 54.
    Machuca TN, Collaud S, Mercier O, Cheung M, Cunningham V, Kim SJ, et al. Outcomes of intraoperative extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantation. J Thorac Cardiovasc Surg. 2015;149(4):1152–7.PubMedCrossRefGoogle Scholar
  55. 55.
    de Perrot M, Imai Y, Volgyesi GA, Waddell TK, Liu M, Mullen JB, et al. Effect of ventilator-induced lung injury on the development of reperfusion injury in a rat lung transplant model. J Thorac Cardiovasc Surg. 2002;124(6):1137–44.PubMedCrossRefGoogle Scholar
  56. 56.
    Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2005;24(10):1454–9.PubMedCrossRefGoogle Scholar
  57. 57.
    Christie JD, Bavaria JE, Palevsky HI, Litzky L, Blumenthal NP, Kaiser LR, et al. Primary graft failure following lung transplantation. Chest. 1998;114(1):51–60.PubMedCrossRefGoogle Scholar
  58. 58.
    Yusen RD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Goldfarb SB, et al. The Registry of the International Society for Heart and Lung Transplantation: thirty-second official adult lung and heart-lung transplantation report–2015; focus theme: early graft failure. J Heart Lung Transplant. 2015;34(10):1264–77.PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    Christie JD, Bellamy S, Ware LB, Lederer D, Hadjiliadis D, Lee J, et al. Construct validity of the definition of primary graft dysfunction after lung transplantation. J Heart Lung Transplant. 2010;29(11):1231–9.PubMedPubMedCentralCrossRefGoogle Scholar
  60. 60.
    Porteous MK, Diamond JM, Christie JD. Primary graft dysfunction: lessons learned about the first 72 h after lung transplantation. Curr Opin Organ Transplant. 2015;20(5):506–14.PubMedPubMedCentralCrossRefGoogle Scholar
  61. 61.
    Lee JC, Christie JD, Keshavjee S. Primary graft dysfunction: definition, risk factors, short- and long-term outcomes. Semin Respir Crit Care Med. 2010;31(2):161–71.PubMedCrossRefGoogle Scholar
  62. 62.
    Meade MO, Granton JT, Matte-Martyn A, McRae K, Weaver B, Cripps P, et al. A randomized trial of inhaled nitric oxide to prevent ischemia-reperfusion injury after lung transplantation. Am J Respir Crit Care Med. 2003;167(11):1483–9.PubMedCrossRefGoogle Scholar
  63. 63.
    Steen S, Sjoberg T, Pierre L, Liao Q, Eriksson L, Algotsson L. Transplantation of lungs from a non-heart-beating donor. Lancet. 2001;357(9259):825–9.PubMedCrossRefGoogle Scholar
  64. 64.
    Cypel M, Yeung JC, Liu M, Anraku M, Chen F, Karolak W, et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med. 2011;364(15):1431–40.PubMedCrossRefGoogle Scholar
  65. 65.
    Van Raemdonck D, Neyrinck A, Cypel M, Keshavjee S. Ex-vivo lung perfusion. Transpl Int. 2015;28(6):643–56.PubMedCrossRefGoogle Scholar
  66. 66.
    Lee JW, Fang X, Gupta N, Serikov V, Matthay MA. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci U S A. 2009;106(38):16357–62.PubMedPubMedCentralCrossRefGoogle Scholar
  67. 67.
    Lee JW, Krasnodembskaya A, McKenna DH, Song Y, Abbott J, Matthay MA. Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria. Am J Respir Crit Care Med. 2013;187(7):751–60.PubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Cassivi SD, Liu M, Boehler A, Tanswell AK, Slutsky AS, Keshavjee S, et al. Transgene expression after adenovirus-mediated retransfection of rat lungs is increased and prolonged by transplant immunosuppression. J Thorac Cardiovasc Surg. 1999;117(1):1–7.PubMedCrossRefGoogle Scholar
  69. 69.
    de Perrot M, Fischer S, Liu M, Imai Y, Martins S, Sakiyama S, et al. Impact of human interleukin-10 on vector-induced inflammation and early graft function in rat lung transplantation. Am J Respir Cell Mol Biol. 2003;28(5):616–25.PubMedCrossRefGoogle Scholar
  70. 70.
    de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991;174(5):1209–20.PubMedCrossRefGoogle Scholar
  71. 71.
    Fischer S, De Perrot M, Liu M, MacLean AA, Cardella JA, Imai Y, et al. Interleukin 10 gene transfection of donor lungs ameliorates posttransplant cell death by a switch from cellular necrosis to apoptosis. J Thorac Cardiovasc Surg. 2003;126(4):1174–80.PubMedCrossRefGoogle Scholar
  72. 72.
    Fischer S, Liu M, MacLean AA, de Perrot M, Ho M, Cardella JA, et al. In vivo transtracheal adenovirus-mediated transfer of human interleukin-10 gene to donor lungs ameliorates ischemia-reperfusion injury and improves early posttransplant graft function in the rat. Hum Gene Ther. 2001;12(12):1513–26.PubMedCrossRefGoogle Scholar
  73. 73.
    Martins S, de Perrot M, Imai Y, Yamane M, Quadri SM, Segall L, et al. Transbronchial administration of adenoviral-mediated interleukin-10 gene to the donor improves function in a pig lung transplant model. Gene Ther. 2004;11(24):1786–96.PubMedCrossRefGoogle Scholar
  74. 74.
    Yeung JC, Wagnetz D, Cypel M, Rubacha M, Koike T, Chun YM, et al. Ex vivo adenoviral vector gene delivery results in decreased vector-associated inflammation pre- and post-lung transplantation in the pig. Mol Ther. 2012;20(6):1204–11.PubMedPubMedCentralCrossRefGoogle Scholar
  75. 75.
    Keshavjee S, Davis RD, Zamora MR, de Perrot M, Patterson GA. A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings. J Thorac Cardiovasc Surg. 2005;129(2):423–8.PubMedCrossRefGoogle Scholar
  76. 76.
    Kermeen FD, McNeil KD, Fraser JF, McCarthy J, Ziegenfuss MD, Mullany D, et al. Resolution of severe ischemia-reperfusion injury post-lung transplantation after administration of endobronchial surfactant. J Heart Lung Transplant. 2007;26(8):850–6.PubMedCrossRefGoogle Scholar
  77. 77.
    Ito K, Shimada J, Kato D, Toda S, Takagi T, Naito Y, et al. Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-gamma ligand, on lung ischemia-reperfusion injury in rats. Eur J Cardiothorac Surg. 2004;25(4):530–6.PubMedCrossRefGoogle Scholar
  78. 78.
    den Hengst WA, Gielis JF, Lin JY, Van Schil PE, De Windt LJ, Moens AL. Lung ischemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological process. Am J Physiol Heart Circ Physiol. 2010;299(5):H1283–99.CrossRefGoogle Scholar
  79. 79.
    Echahidi N, Pibarot P, O’Hara G, Mathieu P. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol. 2008;51(8):793–801.PubMedCrossRefGoogle Scholar
  80. 80.
    See VY, Roberts-Thomson KC, Stevenson WG, Camp PC, Koplan BA. Atrial arrhythmias after lung transplantation: epidemiology, mechanisms at electrophysiology study, and outcomes. Circ Arrhythm Electrophysiol. 2009;2(5):504–10.PubMedCrossRefGoogle Scholar
  81. 81.
    Nielsen TD, Bahnson T, Davis RD, Palmer SM. Atrial fibrillation after pulmonary transplant. Chest. 2004;126(2):496–500.PubMedCrossRefGoogle Scholar
  82. 82.
    Chen SA, Hsieh MH, Tai CT, Tsai CF, Prakash VS, Yu WC, et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation. 1999;100(18):1879–86.PubMedCrossRefGoogle Scholar
  83. 83.
    Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339(10):659–66.PubMedCrossRefGoogle Scholar
  84. 84.
    D’Angelo AM, Chan EG, Hayanga JW, Odell DD, Pilewski J, Crespo M, et al. Atrial arrhythmias after lung transplantation: Incidence and risk factors in 652 lung transplant recipients. J Thorac Cardiovasc Surg. 2016;152(3):901–9.PubMedCrossRefGoogle Scholar
  85. 85.
    Sacher F, Vest J, Raymond JM, Stevenson WG. Incessant donor-to-recipient atrial tachycardia after bilateral lung transplantation. Heart Rhythm. 2008;5(1):149–51.PubMedCrossRefGoogle Scholar
  86. 86.
    Herridge MS, de Hoyos AL, Chaparro C, Winton TL, Kesten S, Maurer JR. Pleural complications in lung transplant recipients. J Thorac Cardiovasc Surg. 1995;110(1):22–6.PubMedPubMedCentralCrossRefGoogle Scholar
  87. 87.
    Ferrer J, Roldan J, Roman A, Bravo C, Monforte V, Pallissa E, et al. Acute and chronic pleural complications in lung transplantation. J Heart Lung Transplant. 2003;22(11):1217–25.PubMedPubMedCentralCrossRefGoogle Scholar
  88. 88.
    Judson MA, Handy JR, Sahn SA. Pleural effusions following lung transplantation. Time course, characteristics, and clinical implications. Chest. 1996;109(5):1190–4.PubMedCrossRefGoogle Scholar
  89. 89.
    Nunley DR, Grgurich WF, Keenan RJ, Dauber JH. Empyema complicating successful lung transplantation. Chest. 1999;115(5):1312–5.PubMedCrossRefGoogle Scholar
  90. 90.
    de la Torre M, Fernandez R, Fieira E, Gonzalez D, Delgado M, Mendez L, et al. Postoperative surgical complications after lung transplantation. Rev Port Pneumol (2006). 2015;21(1):36–40.Google Scholar
  91. 91.
    Gammie JS, Cheul Lee J, Pham SM, Keenan RJ, Weyant RJ, Hattler BG, et al. Cardiopulmonary bypass is associated with early allograft dysfunction but not death after double-lung transplantation. J Thorac Cardiovasc Surg. 1998;115(5):990–7.PubMedCrossRefGoogle Scholar
  92. 92.
    Hussein M, Aljehani YM, Nizami I, Saleh W. Successful management of bilateral refractory chylothorax after double lung transplantation for lymphangioleiomyomatosis. Ann Thorac Med. 2014;9(2):124–6.PubMedPubMedCentralCrossRefGoogle Scholar
  93. 93.
    Clark SC, Levine AJ, Hasan A, Hilton CJ, Forty J, Dark JH. Vascular complications of lung transplantation. Ann Thorac Surg. 1996;61(4):1079–82.PubMedPubMedCentralCrossRefGoogle Scholar
  94. 94.
    Siddique A, Bose AK, Ozalp F, Butt TA, Muse H, Morley KE, et al. Vascular anastomotic complications in lung transplantation: a single institution’s experience. Interact Cardiovasc Thorac Surg. 2013;17(4):625–31.PubMedPubMedCentralCrossRefGoogle Scholar
  95. 95.
    Santacruz JF, Mehta AC. Airway complications and management after lung transplantation: ischemia, dehiscence, and stenosis. Proc Am Thorac Soc. 2009;6(1):79–93.PubMedPubMedCentralCrossRefGoogle Scholar
  96. 96.
    Hyytinen TA, Heikkila LJ, Verkkala KA, Sipponen JT, Vainikka TL, Halme M, et al. Bronchial artery revascularization improves tracheal anastomotic healing after lung transplantation. Scand Cardiovasc J. 2000;34(2):213–8.PubMedCrossRefGoogle Scholar
  97. 97.
    Date H, Trulock EP, Arcidi JM, Sundaresan S, Cooper JD, Patterson GA. Improved airway healing after lung transplantation. An analysis of 348 bronchial anastomoses. J Thorac Cardiovasc Surg. 1995;110(5):1424–32, discussion 1432–3PubMedCrossRefGoogle Scholar
  98. 98.
    Awori Hayanga JW, Aboagye JK, Shigemura N, Hayanga HK, Murphy E, Khaghani A, et al. Airway complications after lung transplantation: contemporary survival and outcomes. J Heart Lung Transplant. 2016;35(10):1206–11.PubMedCrossRefGoogle Scholar
  99. 99.
    Shennib H, Massard G. Airway complications in lung transplantation. Ann Thorac Surg. 1994;57(2):506–11.PubMedCrossRefGoogle Scholar
  100. 100.
    Garfein ES, Ginsberg ME, Gorenstein L, McGregor CC, Schulman LL. Superiority of end-to-end versus telescoped bronchial anastomosis in single lung transplantation for pulmonary emphysema. J Thorac Cardiovasc Surg. 2001;121(1):149–54.PubMedCrossRefGoogle Scholar
  101. 101.
    Van De Wauwer C, Van Raemdonck D, Verleden GM, Dupont L, De Leyn P, Coosemans W, et al. Risk factors for airway complications within the first year after lung transplantation. Eur J Cardiothorac Surg. 2007;31(4):703–10.CrossRefGoogle Scholar
  102. 102.
    Mulligan MS. Endoscopic management of airway complications after lung transplantation. Chest Surg Clin N Am. 2001;11(4):907–15.PubMedGoogle Scholar
  103. 103.
    Herrera JM, McNeil KD, Higgins RS, Coulden RA, Flower CD, Nashef SA, et al. Airway complications after lung transplantation: treatment and long-term outcome. Ann Thorac Surg. 2001;71(3):989–93, discussion 993–4PubMedCrossRefGoogle Scholar
  104. 104.
    Krishnam MS, Suh RD, Tomasian A, Goldin JG, Lai C, Brown K, et al. Postoperative complications of lung transplantation: radiologic findings along a time continuum. Radiographics. 2007;27(4):957–74.PubMedPubMedCentralCrossRefGoogle Scholar
  105. 105.
    Mughal MM, Gildea TR, Murthy S, Pettersson G, DeCamp M, Mehta AC. Short-term deployment of self-expanding metallic stents facilitates healing of bronchial dehiscence. Am J Respir Crit Care Med. 2005;172(6):768–71.PubMedCrossRefGoogle Scholar
  106. 106.
    De Gracia J, Culebras M, Alvarez A, Catalan E, De la Rosa D, Maestre J, et al. Bronchoscopic balloon dilatation in the management of bronchial stenosis following lung transplantation. Respir Med. 2007;101(1):27–33.PubMedPubMedCentralCrossRefGoogle Scholar
  107. 107.
    Marulli G, Loy M, Rizzardi G, Calabrese F, Feltracco P, Sartori F, et al. Surgical treatment of posttransplant bronchial stenoses: case reports. Transplant Proc. 2007;39(6):1973–5.PubMedCrossRefGoogle Scholar
  108. 108.
    Hasegawa T, Iacono AT, Orons PD, Yousem SA. Segmental nonanastomotic bronchial stenosis after lung transplantation. Ann Thorac Surg. 2000;69(4):1020–4.PubMedCrossRefGoogle Scholar
  109. 109.
    Madden BP, Kumar P, Sayer R, Murday A. Successful resection of obstructing airway granulation tissue following lung transplantation using endobronchial laser (Nd:YAG) therapy. Eur J Cardiothorac Surg. 1997;12(3):480–5.PubMedCrossRefGoogle Scholar

Copyright information

© The Author(s) 2018

Authors and Affiliations

  1. 1.Division of Thoracic SurgeryToronto General Hospital, University Health NetworkTorontoCanada
  2. 2.Toronto Lung Transplant ProgramToronto General Hospital, University Health Network, University of TorontoTorontoCanada

Personalised recommendations